MMED
NASD MiniMed Group, Inc.$16.74 ↓ -0.07 (-0.42%) Trading Down from the previous close of $16.81
- YTD change
- -9.46%
- vs 20-day SMA
- -16.05%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+1.59 (+10.45%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 31.5% away from all-time highs of $24.43
- MMED is down 9% since the beginning of the year
- MMED is down 9% over the past 12 months
- MMED is down 25% over the past 1 month
- 67% of all MMED investors are betting against MMED
MMED reads poor: the 12-month move is -9.1%.
- Previous minute
- +$0.00
- Last hour
- -$0.06
- Last 5 days
- -12.40%
- vs 8-day SMA
- -12.14%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was founded by Alfred E. Mann in 1983 and is headquartered in Northridge, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.